ACOG Calls for Routine Cannabis Screening as Use Reaches 7% in Pregnancy – Fertility Plus
Fertility Plus shared a post on LinkedIn:
“Cannabis is linked to higher rates of preterm birth, low birth weight, and neurodevelopmental issues in babies. Many still think it’s safe—it’s not risk-free!
The American College of Obstetricians and Gynecologists (ACOG) now calls for universal screening of all reproductive-aged individuals for cannabis use during prepregnancy, pregnancy, and lactation. This shift responds to rising cannabis use—now up to 7% in pregnancy—amid nationwide legalization. Research confirms increased risks of preterm birth, low birth weight, and neurodevelopmental impacts in exposed infants. Clinicians are urged to use interviews and validated tools, avoiding biologic drug tests that can result in inequitable care. ACOG highlights the need for evidence-based counseling and risk-reduction strategies personalized to each patient.”

Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Aug 3, 2026, 14:19Asmaa Khaled: The Success of IVF is Not Determined By the Number of Eggs Retrieved Alone…
-
Aug 3, 2026, 14:03Clare Mansfield: Sometimes the Path to Parenthood Changes, but the Dream Doesn’t Have To
-
Aug 3, 2026, 13:45Undiga Emuekpere: Basic Fertility Health Awareness Could Change Outcomes
-
Aug 3, 2026, 13:31Priyadatt Patel: A Quiet Inefficiency in How We Approach Infertility Deserves More Attention
-
Aug 3, 2026, 13:21Purabi Gunjal: Most Women Start Thinking about Fertility Too Late…
-
Aug 3, 2026, 13:10Juhee Jain: Empowering Women with the Right Information to Make Informed Decisions
-
Aug 3, 2026, 12:57Ashley Evans: Sometimes, the Thing that Got Me Through Fertility Treatment Wasn’t Positivity…
-
Aug 3, 2026, 12:42Devyanshi Dixit: Why Do the Best Healthcare Professionals Never Stop Learning?
-
Aug 3, 2026, 12:30Bringing Together the Brightest Minds in Reproductive Medicine for 3 Days at MEFS 2026
